Mevalonate Kinase (MVK) Peptide
Quick Overview for Mevalonate Kinase (MVK) Peptide (ABIN940193)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- LAVLAFLYLY LSICRKQRAL PSLDIVVWSE LPPGAGLGSS AAYSVCLAAA
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of MVK antibody,
Alternative Names: MVK control peptide, MVK antibody Blocking Peptide, Anti-MVK Blocking Peptide, Mevalonate Kinase Blocking Peptide, LRBP Blocking Peptide, MVLK Blocking Peptide -
Purification
- The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- MVK (Mevalonate Kinase (MVK))
-
Background
- MVK is the peroxisomal enzyme mevalonate kinase. Mevalonate is a key intermediate, and mevalonate kinase a key early enzyme, in isoprenoid and sterol synthesis. Mevalonate kinase deficiency caused by mutation of this gene results in mevalonic aciduria, a disease characterized psychomotor retardation, failure to thrive, hepatosplenomegaly, anemia and recurrent febrile crises. Defects in this gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder characterized by recurrent episodes of fever associated with lymphadenopathy, arthralgia, gastrointestinal dismay and skin rash.
-
Molecular Weight
- 42 kDa
Target
-